Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8⁺ T cells during picornavirus infection

Medicine & Life Sciences

• Picornaviridae Infections 100%
• Enterovirus 63%
• Lymphocytic choriomeningitis virus 61%
• Cytotoxic T-Lymphocytes 47%
• T-Lymphocyte Epitopes 39%
• Epitopes 37%
• T-Lymphocytes 34%
• Viral Load 32%
• Polyproteins 29%
• Myocarditis 24%
• Viruses 22%
• Pancreatitis 21%
• Pancreas 18%
• Coxsackievirus Infections 16%
• Infections 15%
• Cross-Priming 15%
• Picornaviridae 15%
• Virus Assembly 14%
• Viral Proteins 11%
• Major Histocompatibility Complex 11%
• Glycine 11%
• Growth 11%
• Open Reading Frames 10%
• Vaccines 8%
• Virus Diseases 8%
• Kinetics 7%
• Genome 7%
• Heart 7%
• Peptides 7%
• In Vitro Techniques 4%
• Proteins 4%

Agriculture & Biology

• Picornaviridae 77%
• Enterovirus 69%
• Lymphocytic choriomeningitis mammarenavirus 53%
• epitopes 53%
• T-lymphocytes 50%
• cytotoxic T-lymphocytes 44%
• infection 29%
• viral load 27%
• myocarditis 23%
• pancreatitis 22%
• viruses 20%
• polyproteins 20%
• mice 18%
• pancreas 15%
• vector vaccines 12%
• recombinant peptides 12%
• major histocompatibility complex 9%
• viral proteins 9%
• animal pathogens 8%
• tissue culture 7%
• cleavage (chemistry) 6%
• immune response 6%
• open reading frames 6%
• heart 6%
• kinetics 5%
• pathogens 4%
• genome 4%
• proteins 2%
• cells 2%